Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Circassia Limited
With
Adiga Life Sciences, Inc.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female, aged 18-65 years.
Reliable history consistent with moderate to severe rhinoconjunctivitis on exposure to ragweed for at least the previous two seasons.
Minimum qualifying rhinoconjunctivitis symptom scores
Ragweed-specific Immunoglobulin E (IgE) \> 0.70 kU/L.
You may not be if
Subjects with a history of ragweed pollen induced asthma
A history of anaphylaxis to ragweed allergen.
FEV1 \< 80 % of predicted.
Subjects who cannot tolerate Baseline Challenge in the EEC.
Subjects for whom administration of epinephrine is contraindicated (e.g. subjects with acute or chronic symptomatic coronary heart disease or severe hypertension).
History of immunopathological diseases (e.g. multiple sclerosis) that in the opinion of the Investigator or the Sponsor could interfere with the results obtained from the study.
A history of severe drug allergy, severe angioedema or anaphylactic reaction to food.
A history of any significant disease or disorder (e.g. cardiovascular, pulmonary, gastrointestinal, liver, renal, neurological, musculoskeletal, endocrine, metabolic, neoplastic/malignant, psychiatric, major physical impairment)